Related Experiment Videos
Epitheliomas in patients receiving razoxane therapy for psoriasis
The British Journal of Dermatology
|December 1, 1983
Summary
Two patients with psoriasis developed skin cancer while on razoxane treatment. This suggests a potential link between razoxane therapy and the development of cutaneous squamous cell carcinomata.
Area of Science:
- Dermatology
- Oncology
Background:
- Psoriasis is a chronic inflammatory skin condition.
- Razoxane is a medication sometimes used for psoriasis treatment.
Observation:
- Two patients with psoriasis on razoxane therapy developed cutaneous squamous cell carcinomata.
- The development of these tumors occurred during or after razoxane treatment.
Findings:
- A potential association between razoxane therapy and the development of skin cancer in psoriasis patients is suggested.
- The role of past psoriasis treatments in tumor etiology is also considered.
Implications:
- Further investigation into the oncogenic potential of razoxane in dermatological conditions is warranted.
- This finding may influence treatment decisions for psoriasis patients, particularly those with a history of skin cancer or prolonged medication use.